BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24145533)

  • 1. A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease.
    Yang CC; Hu HS; Wu RH; Wu SH; Lee SJ; Jiaang WT; Chern JH; Huang ZS; Wu HN; Chang CM; Yueh A
    Antimicrob Agents Chemother; 2014; 58(1):110-9. PubMed ID: 24145533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.
    Yang CC; Hsieh YC; Lee SJ; Wu SH; Liao CL; Tsao CH; Chao YS; Chern JH; Wu CP; Yueh A
    Antimicrob Agents Chemother; 2011 Jan; 55(1):229-38. PubMed ID: 20937790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
    Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
    Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
    Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
    Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antiviral activity of bromocriptine against dengue virus replication.
    Kato F; Ishida Y; Oishi S; Fujii N; Watanabe S; Vasudevan SG; Tajima S; Takasaki T; Suzuki Y; Ichiyama K; Yamamoto N; Yoshii K; Takashima I; Kobayashi T; Miura T; Igarashi T; Hishiki T
    Antiviral Res; 2016 Jul; 131():141-7. PubMed ID: 27181378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
    Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
    J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
    Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
    Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
    Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
    Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an Arylnaphthalene Lignan Derivative as an Inhibitor against Dengue Virus Serotypes 1 to 4 (DENV-1 to -4) Using a Newly Developed DENV-3 Infectious Clone and Replicon.
    Hu M; Li WF; Wu T; Yang Y; Chen G; Chen T; Liu Y; Mei Y; Wu D; Wei Y; Luo T; Zhang HJ; Li YP
    Microbiol Spectr; 2023 Aug; 11(4):e0042323. PubMed ID: 37378517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
    Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
    Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication.
    Pambudi S; Kawashita N; Phanthanawiboon S; Omokoko MD; Masrinoul P; Yamashita A; Limkittikul K; Yasunaga T; Takagi T; Ikuta K; Kurosu T
    Biochem Biophys Res Commun; 2013 Oct; 440(3):393-8. PubMed ID: 24070610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
    Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
    Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.
    Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R
    Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs.
    Kato F; Kobayashi T; Tajima S; Takasaki T; Miura T; Igarashi T; Hishiki T
    Jpn J Infect Dis; 2014; 67(3):209-12. PubMed ID: 24858611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.